Oncology
Brain tumor
1
1
Head and Neck cancer
2
4
Breast cancer (Early)
3
82
Breast cancer (Advanced)
4
108
NSCLC (Early)
5
110
NSCLC (Advanced)
6
16
SCLC
7
17
Esophageal cancer
8
91
Gastric cancer
9
18
Colorectal cancer
10
78
Hepato-Biliary
11
48
Pancreatic cancer
12
113
Renal cell carcinoma
13
84
Urothelial carcinoma
14
19
Prostate cancer
15
90
Germ cell tumor
16
85
GY cancer
17
88
Neuroendocrine cancer
18
79
Sarcoma
19
83
Melanoma / Skin cancer
20
81
Thymic ca / Mesothelioma
21
89
MUO / Rare cancer
22
96
Hematology
B-NHL
1
5
T-NHL
2
111
Hodgkin lymphoma
3
105
Histiocytic sarcoma
4
121
Multiple Myeloma
5
6
CLL / LPD / HLH
6
103
CML / MPN
7
100
MDS / AA / PNH
8
99
AML
9
87
ALL
10
86
Auto-HSCT
11
101
Allo-HSCT
12
102
CART
13
104
ITP / TTP / Anemia
14
97
CNS prophylaxis
15
106
Others
Special Medicine
16
107
Supportive care
17
122
General Medicine
18
98
Nursing care
19
117
Oncology
Hematology
Others
Disease
Save
Regimen list
Primary
R-CHOP
B-NHL
R-CHOP
1
2
Prophylaxis
IV HD-MTX for CNS prophylaxis
CNS prophylaxis
IV HD-MTX for CNS prophylaxis
1
5
Primary
ABVD for HL
Hodgkin lymphoma
ABVD for HL
1
29
Neoadjuvant
TCHP
Breast cancer (Early)
TCHP
1
13
Neoadjuvant
CCRT with FP
Esophageal cancer
CCRT with FP
1
14
Adjuvnat
GIST : Imatinib for GIST
Sarcoma
GIST : Imatinib for GIST
1
18
Definitive
CCRT with Cisplatin weekly
Head and Neck cancer
CCRT with Cisplatin weekly
1
63
Adjuvnat
TS-1
Gastric cancer
TS-1
1
35
Neoadjuvant
CCRT with Xeloda / XELOX
Colorectal cancer
CCRT with Xeloda / XELOX
1
51
Palliative
EGFR TKI
NSCLC (Advanced)
EGFR TKI
1
65
Primary
CHOP / CHOEP
T-NHL
CHOP / CHOEP
1
192
Definitive
Definitive CCRT with EP
SCLC
Definitive CCRT with EP
1
105
Palliative
Hormone therapy
Breast cancer (Advanced)
Hormone therapy
1
126
Supportive
Pre-Post medication
Supportive care
Pre-Post medication
1
142
Consolidation
Durvalumab
NSCLC (Early)
Durvalumab
1
149
Palliative
Nivolumab + Ipilimumab
Renal cell carcinoma
Nivolumab + Ipilimumab
1
150
Palliative
Sunitinb / Everolimus for NET
Neuroendocrine cancer
Sunitinb / Everolimus for NET
1
152
Medicine
HTN / DL / Anti-Plt
General Medicine
HTN / DL / Anti-Plt
1
160
Medicine
Cancer pain
Special Medicine
Cancer pain
1
164
Palliative
HCC : Atezolizumab + Bevacizumab
Hepato-Biliary
HCC : Atezolizumab + Bevacizumab
1
171
Perioperative
FOLFIRINOX
Pancreatic cancer
FOLFIRINOX
1
178
Adjuvnat
Gemcitabine + Platinum
Urothelial carcinoma
Gemcitabine + Platinum
1
180
Adjuvnat
BEP
Germ cell tumor
BEP
1
183
Document
MM staging : R-ISS
Multiple Myeloma
MM staging : R-ISS
1
245
Supportive
Patient Care
Nursing care
Patient Care
1
257
Document
CLL Staging
CLL / LPD / HLH
CLL Staging
1
277
Document
Schedule of ASCT
Auto-HSCT
Schedule of ASCT
1
279
Document
DDx of Histiocytic disease
Histiocytic sarcoma
DDx of Histiocytic disease
1
296
Document
CTx Based on IDH Status
Brain tumor
CTx Based on IDH Status
1
304
Document
CML : Response Criteria
CML / MPN
CML : Response Criteria
1
305
Palliative
Immunotherapy
Melanoma / Skin cancer
Immunotherapy
1
335
Adjuvnat
CCRT with temozolomide
Brain tumor
CCRT with temozolomide
2
12
Salvage
R-ICED (Modified)
B-NHL
R-ICED (Modified)
2
15
Palliative
GIST : TKI for GIST
Sarcoma
GIST : TKI for GIST
2
19
Palliative
FOLFIRINOX
Pancreatic cancer
FOLFIRINOX
2
22
Palliative
VEGF / mTOR TKI
Renal cell carcinoma
VEGF / mTOR TKI
2
26
Adjuvnat
XELOX
Gastric cancer
XELOX
2
40
Adjuvnat
XELOX / Xeloda
Colorectal cancer
XELOX / Xeloda
2
50
Supportive
Antiemetics
Supportive care
Antiemetics
2
141
Definitive
CCRT with Cisplatin
Head and Neck cancer
CCRT with Cisplatin
2
64
Salvage
ICE-D
T-NHL
ICE-D
2
194
Prophylaxis
IT MTX for CNS prophylaxis
CNS prophylaxis
IT MTX for CNS prophylaxis
2
91
Primary
A-AVD for HL
Hodgkin lymphoma
A-AVD for HL
2
96
Palliative
ALK TKI
NSCLC (Advanced)
ALK TKI
2
101
Adjuvnat
Etoposide + Platinum
SCLC
Etoposide + Platinum
2
107
Palliative
Ribociclib +AI
Breast cancer (Advanced)
Ribociclib +AI
2
125
Palliative
Etoposide + Platinum
Neuroendocrine cancer
Etoposide + Platinum
2
153
Medicine
DM / Osteoporosis / Thyroid
General Medicine
DM / Osteoporosis / Thyroid
2
159
Medicine
Peripheral neuropathy
Special Medicine
Peripheral neuropathy
2
163
Palliative
HCC : TKI
Hepato-Biliary
HCC : TKI
2
172
Supportive
Stem Cell Mobilization
Auto-HSCT
Stem Cell Mobilization
2
197
Palliative
Nivolumab + GP
Urothelial carcinoma
Nivolumab + GP
2
182
Salvage
TIP
Germ cell tumor
TIP
2
184
Neoadjuvant
AC #4 → Docetaxel #4
Breast cancer (Early)
AC #4 → Docetaxel #4
2
199
Supportive
Extravasation
Nursing care
Extravasation
2
262
Primary
CLL : R-FC
CLL / LPD / HLH
CLL : R-FC
2
275
Document
MM response : IMWG
Multiple Myeloma
MM response : IMWG
2
284
Primary
CML : TKIs
CML / MPN
CML : TKIs
2
294
Primary
CHOP for HS
Histiocytic sarcoma
CHOP for HS
2
297
Neoadjuvant
CCRT with PC
Esophageal cancer
CCRT with PC
2
321
Neoadjuvant
Paclitaxel + Platinium
GY cancer
Paclitaxel + Platinium
2
324
Palliative
BRAF/MEK inhibitor
Melanoma / Skin cancer
BRAF/MEK inhibitor
2
334
Salvage
R-GDP
B-NHL
R-GDP
3
9
Palliative
IP
Neuroendocrine cancer
IP
3
217
Palliative
IL-2
Renal cell carcinoma
IL-2
3
28
Palliative
Nivolumab + FOLFOX / XELOX
Gastric cancer
Nivolumab + FOLFOX / XELOX
3
43
Palliative
PCV for Brain tumor
Brain tumor
PCV for Brain tumor
3
47
Adjuvnat
FOLFOX / FOLFIRI
Colorectal cancer
FOLFOX / FOLFIRI
3
48
Neoadjuvant
CCRT with PC weekly
Esophageal cancer
CCRT with PC weekly
3
71
Alternative
IT MTX + Ara-C
CNS prophylaxis
IT MTX + Ara-C
3
90
Salvage
Brentuximab for HL
Hodgkin lymphoma
Brentuximab for HL
3
100
Palliative
Atezolizumab + EC
SCLC
Atezolizumab + EC
3
106
Definitive
CCRT with Cetuximab
Head and Neck cancer
CCRT with Cetuximab
3
116
Supportive
Co-medication
Supportive care
Co-medication
3
123
Palliative
Everolimus + Exemestane
Breast cancer (Advanced)
Everolimus + Exemestane
3
127
Palliative
PD-1 / PD-L1 inhibitors
NSCLC (Advanced)
PD-1 / PD-L1 inhibitors
3
147
Medicine
HBV / HCV / Hepatotonics
General Medicine
HBV / HCV / Hepatotonics
3
161
Medicine
Hypercalcemia
Special Medicine
Hypercalcemia
3
165
Palliative
Pembro + PADCEV
Urothelial carcinoma
Pembro + PADCEV
3
247
Palliative
HCC : AC
Hepato-Biliary
HCC : AC
3
226
Palliative
Gem + Abraxane
Pancreatic cancer
Gem + Abraxane
3
177
Salvage
VIP
Germ cell tumor
VIP
3
185
Adjuvnat
STS : SWOG Protocol (AP-AI)
Sarcoma
STS : SWOG Protocol (AP-AI)
3
187
Salvage
GDP
T-NHL
GDP
3
193
Neoadjuvant
Docetaxel+Doxorubicin (DA)
Breast cancer (Early)
Docetaxel+Doxorubicin (DA)
3
263
Primary
CLL : Obinu + Chlorambucil
CLL / LPD / HLH
CLL : Obinu + Chlorambucil
3
276
Supportive
Plerixafor (Mozobil)
Auto-HSCT
Plerixafor (Mozobil)
3
306
Salvage
ICE for HS
Histiocytic sarcoma
ICE for HS
3
309
Salvage
MF : Ruxolitinib / Fedratinib
CML / MPN
MF : Ruxolitinib / Fedratinib
3
312
Induction
DVTd for TE NDMM
Multiple Myeloma
DVTd for TE NDMM
3
322
Palliative
Bevacizumab + TC
GY cancer
Bevacizumab + TC
3
325
Palliative
Dacarbazine + Cisplatin
Melanoma / Skin cancer
Dacarbazine + Cisplatin
3
336
Palliative
XELOX / XP / Xeloda
Gastric cancer
XELOX / XP / Xeloda
4
8
Palliative
STS : Pazopanib
Sarcoma
STS : Pazopanib
4
21
Palliative
Bevacizumab + FOLFOX / FOLFIRI
Colorectal cancer
Bevacizumab + FOLFOX / FOLFIRI
4
23
Palliative
Temsirolimus for Non-clear cell
Renal cell carcinoma
Temsirolimus for Non-clear cell
4
27
Palliative
NL irinotecan + FL
Pancreatic cancer
NL irinotecan + FL
4
30
Supportive
Peg-GCSF
Supportive care
Peg-GCSF
4
37
Primary
R-Hyper-CVAD
B-NHL
R-Hyper-CVAD
4
58
Palliative
PemCis
NSCLC (Advanced)
PemCis
4
66
Definitive
CCRT with FOLFOX
Esophageal cancer
CCRT with FOLFOX
4
74
Primary
Hyper-CVAD
T-NHL
Hyper-CVAD
4
88
Salvage
Pembrolizumab for HL
Hodgkin lymphoma
Pembrolizumab for HL
4
97
Primary
CLL : Zanubrutinib
CLL / LPD / HLH
CLL : Zanubrutinib
4
188
Palliative
Etoposide + Platinum
SCLC
Etoposide + Platinum
4
102
Palliative
PTD
Breast cancer (Advanced)
PTD
4
129
Palliative
VIP
Neuroendocrine cancer
VIP
4
151
Medicine
Respiratory /Allergy
General Medicine
Respiratory /Allergy
4
158
Palliative
HCC : FP
Hepato-Biliary
HCC : FP
4
173
Medicine
Hyponatremia
Special Medicine
Hyponatremia
4
329
Palliative
GP → Avelumab
Urothelial carcinoma
GP → Avelumab
4
204
Definitive
CCRT with Carboplatin
Head and Neck cancer
CCRT with Carboplatin
4
266
Neoadjuvant
Pem-TC
Breast cancer (Early)
Pem-TC
4
274
Prophylaxis
Prophylaxis for ASCT
Auto-HSCT
Prophylaxis for ASCT
4
281
Induction
VRd for TE NDMM
Multiple Myeloma
VRd for TE NDMM
4
283
Palliative
Temozolomide / Temo+Cis
Brain tumor
Temozolomide / Temo+Cis
4
303
Primary
Vinblastine + PD for LCH/ECD
Histiocytic sarcoma
Vinblastine + PD for LCH/ECD
4
307
Palliative
Paclitaxel + Carboplatin
Melanoma / Skin cancer
Paclitaxel + Carboplatin
4
337
Primary
DA-EPOCH-R
B-NHL
DA-EPOCH-R
5
6
Primary
VRd for TIE NDMM
Multiple Myeloma
VRd for TIE NDMM
5
11
Palliative
FOLFOX / FOLFIRI
Gastric cancer
FOLFOX / FOLFIRI
5
31
Palliative
Irinotecan + Bevacizumab
Brain tumor
Irinotecan + Bevacizumab
5
45
Palliative
Cetuximab + FOLFOX / FOLFIRI
Colorectal cancer
Cetuximab + FOLFOX / FOLFIRI
5
60
Perioperative
FLOT for ESCC
Esophageal cancer
FLOT for ESCC
5
72
Primary
A-CHP for CD30+ sALCL
T-NHL
A-CHP for CD30+ sALCL
5
93
Salvage
Nivolumab for HL
Hodgkin lymphoma
Nivolumab for HL
5
98
Palliative
Irinotecan + Platinum
SCLC
Irinotecan + Platinum
5
104
Induction
DPF
Head and Neck cancer
DPF
5
110
Salvage
CLL : Venetoclax + Rituximab
CLL / LPD / HLH
CLL : Venetoclax + Rituximab
5
114
Palliative
Trastuzumab + Docetaxel
Breast cancer (Advanced)
Trastuzumab + Docetaxel
5
121
Palliative
Pembrolizumab + PemCis
NSCLC (Advanced)
Pembrolizumab + PemCis
5
145
Medicine
GI medication
General Medicine
GI medication
5
167
Medicine
Tumor lysis syndrome
Special Medicine
Tumor lysis syndrome
5
196
Adjuvnat
AC #4 → Docetaxel / Paclitaxel #4
Breast cancer (Early)
AC #4 → Docetaxel / Paclitaxel #4
5
200
Adjuvnat
FL for AoV Cancer
Hepato-Biliary
FL for AoV Cancer
5
227
Palliative
Pembrolizumab
Urothelial carcinoma
Pembrolizumab
5
238
Conditioning
Melphalan
Auto-HSCT
Melphalan
5
280
Salvage
Cladribine for LCH/ECD/RDD
Histiocytic sarcoma
Cladribine for LCH/ECD/RDD
5
310
Palliative
TS-1
Pancreatic cancer
TS-1
5
323
Palliative
PRRT
Neuroendocrine cancer
PRRT
5
338
Palliative
DP
Head and Neck cancer
DP
6
7
Palliative
Weekly Paclitaxel
Urothelial carcinoma
Weekly Paclitaxel
6
10
Primary
R-CVP for nodal MZL
B-NHL
R-CVP for nodal MZL
6
17
Palliative
DP : Docetaxel + Cisplatin
Gastric cancer
DP : Docetaxel + Cisplatin
6
33
Palliative
EC for Brain Tumor
Brain tumor
EC for Brain Tumor
6
44
Palliative
Cetuximab + Irinotecan
Colorectal cancer
Cetuximab + Irinotecan
6
59
Primary
Rd for TIE NDMM
Multiple Myeloma
Rd for TIE NDMM
6
68
Perioperative
Nivolumab + ipilimumab
Esophageal cancer
Nivolumab + ipilimumab
6
73
Salvage
LPD : Zanubrutinib for LPL (WM)
CLL / LPD / HLH
LPD : Zanubrutinib for LPL (WM)
6
94
Salvage
Brentuximab CD30+NHL
T-NHL
Brentuximab CD30+NHL
6
99
Palliative
Topotecan
SCLC
Topotecan
6
109
Palliative
Trastuzumab emtansine (T-DM1)
Breast cancer (Advanced)
Trastuzumab emtansine (T-DM1)
6
124
Palliative
Pembrolizumab + PemCarbo
NSCLC (Advanced)
Pembrolizumab + PemCarbo
6
146
Medicine
BPH / Nuerogenic bladder
General Medicine
BPH / Nuerogenic bladder
6
162
Adjuvnat
Biliary : Capecitabine
Hepato-Biliary
Biliary : Capecitabine
6
170
Medicine
CRS management
Special Medicine
CRS management
6
181
Conditioning
BuCyEtopo
Auto-HSCT
BuCyEtopo
6
221
Adjuvnat
Dose-dense AC #4 → W-Paclitaxel
Breast cancer (Early)
Dose-dense AC #4 → W-Paclitaxel
6
273
Palliative
Low-dose Oral MTX
Histiocytic sarcoma
Low-dose Oral MTX
6
308
Palliative
Kaposi : Lipo-Doxorubicin
Sarcoma
Kaposi : Lipo-Doxorubicin
6
313
Palliative
CAPTEM
Neuroendocrine cancer
CAPTEM
6
330
Primary
BR for Stage 3-4 FL
B-NHL
BR for Stage 3-4 FL
7
4
Palliative
Biliary : GP
Hepato-Biliary
Biliary : GP
7
25
Palliative
Ramucirumab + Paclitaxel
Gastric cancer
Ramucirumab + Paclitaxel
7
34
Palliative
Bevacizumab
Brain tumor
Bevacizumab
7
46
Adjuvnat
Nivolumab for ESCC
Esophageal cancer
Nivolumab for ESCC
7
70
Induction
NKTCL : CCRT + VIPD
T-NHL
NKTCL : CCRT + VIPD
7
85
Palliative
Paclitaxel
SCLC
Paclitaxel
7
103
Palliative
DIP
Head and Neck cancer
DIP
7
111
Palliative
Trastuzumab deruxtecan (T-DXd)
Breast cancer (Advanced)
Trastuzumab deruxtecan (T-DXd)
7
131
Palliative
Pembrolizumab + TC
NSCLC (Advanced)
Pembrolizumab + TC
7
148
Medicine
IICP control
Special Medicine
IICP control
7
166
Medicine
Topical / Gargle agents
General Medicine
Topical / Gargle agents
7
168
Palliative
CMV
Urothelial carcinoma
CMV
7
202
Palliative
CVD for Pheo
Neuroendocrine cancer
CVD for Pheo
7
218
Palliative
Encorafenib + Cetuximab
Colorectal cancer
Encorafenib + Cetuximab
7
222
Adjuvnat
Docetaxel + Cyclophosphamide
Breast cancer (Early)
Docetaxel + Cyclophosphamide
7
271
Salvage
Vd
Multiple Myeloma
Vd
7
291
Conditioning
ThioBuCy for CNS
Auto-HSCT
ThioBuCy for CNS
7
293
Salvage
Low-dose Cytarabine
Histiocytic sarcoma
Low-dose Cytarabine
7
311
Palliative
TS-1+Cisplatin / TS-1
Gastric cancer
TS-1+Cisplatin / TS-1
8
32
Palliative
Weekly Paclitaxel
Esophageal cancer
Weekly Paclitaxel
8
56
Palliative
Pembrolizumab
Colorectal cancer
Pembrolizumab
8
62
Palliative
Paclitaxel + Platinum
NSCLC (Advanced)
Paclitaxel + Platinum
8
67
Primary
NKTCL : VIDL for Advanced NKTCL
T-NHL
NKTCL : VIDL for Advanced NKTCL
8
83
Palliative
TS-1 / TS-1+Cisplatin
Head and Neck cancer
TS-1 / TS-1+Cisplatin
8
118
Palliative
Trastuzumab + Anastrozole
Breast cancer (Advanced)
Trastuzumab + Anastrozole
8
130
Medicine
DIC management
Special Medicine
DIC management
8
169
Palliative
Paclitaxel + Ifosfamide
SCLC
Paclitaxel + Ifosfamide
8
189
Palliative
M-VAC
Urothelial carcinoma
M-VAC
8
203
Palliative
EDP for ACC
Neuroendocrine cancer
EDP for ACC
8
219
Palliative
Biliary : Durvalumab + GP
Hepato-Biliary
Biliary : Durvalumab + GP
8
228
Palliative
Lomustine
Brain tumor
Lomustine
8
239
Adjuvnat
Capecitabine
Breast cancer (Early)
Capecitabine
8
272
Salvage
BO for rrFL
B-NHL
BO for rrFL
8
282
Salvage
Pd
Multiple Myeloma
Pd
8
287
Supportive
Post-ASCT Vaccination
Auto-HSCT
Post-ASCT Vaccination
8
314
Salvage
R2 for rrFL
B-NHL
R2 for rrFL
9
16
Palliative
Nivolumab + XP
Gastric cancer
Nivolumab + XP
9
41
Palliative
XELOX / Xeloda
Colorectal cancer
XELOX / Xeloda
9
52
Palliative
DP
Esophageal cancer
DP
9
54
Palliative
Biliary : FP / FOLFOX
Hepato-Biliary
Biliary : FP / FOLFOX
9
69
Primary
NKTCL : SMILE for Advanced NKTCL
T-NHL
NKTCL : SMILE for Advanced NKTCL
9
86
Palliative
GP for NPC
Head and Neck cancer
GP for NPC
9
112
Palliative
Lapatinib + Letrozole
Breast cancer (Advanced)
Lapatinib + Letrozole
9
128
Palliative
Docetaxel + Platinum
NSCLC (Advanced)
Docetaxel + Platinum
9
144
Medicine
Drug hypersensitivity
Special Medicine
Drug hypersensitivity
9
157
Palliative
CAV
SCLC
CAV
9
190
Palliative
GX for ACC
Neuroendocrine cancer
GX for ACC
9
220
Palliative
Lomustine and Bevacizumab
Brain tumor
Lomustine and Bevacizumab
9
240
Palliative
Enfortumab Vedotin (Padcev)
Urothelial carcinoma
Enfortumab Vedotin (Padcev)
9
242
Salvage
Kd
Multiple Myeloma
Kd
9
286
Palliative
Trastuzumab + XP for Her2+
Gastric cancer
Trastuzumab + XP for Her2+
10
38
Palliative
Tislelizumab
Esophageal cancer
Tislelizumab
10
78
Salvage
MF/SS : Mogamulizumab
T-NHL
MF/SS : Mogamulizumab
10
95
Palliative
Lurbinectedin
SCLC
Lurbinectedin
10
108
Palliative
Cetuximab + FP
Head and Neck cancer
Cetuximab + FP
10
117
Palliative
AC
Breast cancer (Advanced)
AC
10
133
Palliative
Gemcitabine + Platinum
NSCLC (Advanced)
Gemcitabine + Platinum
10
143
Palliative
Biliary : FGFR2 TKI
Hepato-Biliary
Biliary : FGFR2 TKI
10
201
Palliative
Sacituzumab govitecan (Trodelvy)
Urothelial carcinoma
Sacituzumab govitecan (Trodelvy)
10
243
Palliative
Dabrafenib for ATC
Neuroendocrine cancer
Dabrafenib for ATC
10
258
Salvage
KRd
Multiple Myeloma
KRd
10
289
Medicine
Drug-induced Complication
Special Medicine
Drug-induced Complication
10
320
Salvage
Rituximab monotherpy for rrFL
B-NHL
Rituximab monotherpy for rrFL
10
333
Palliative
Trastuzumab + FP for Her2+
Gastric cancer
Trastuzumab + FP for Her2+
11
42
Palliative
FP
Esophageal cancer
FP
11
55
Palliative
VIP
Head and Neck cancer
VIP
11
236
Palliative
DX : Docetaxel + Capecitabine
Breast cancer (Advanced)
DX : Docetaxel + Capecitabine
11
140
Palliative
Gemcitabine + Vinorelbine
NSCLC (Advanced)
Gemcitabine + Vinorelbine
11
156
Palliative
Biliary : Pembrolizumab
Hepato-Biliary
Biliary : Pembrolizumab
11
229
Palliative
Erdafitinib (Balversa)
Urothelial carcinoma
Erdafitinib (Balversa)
11
244
Salvage
ZO for rrFL
B-NHL
ZO for rrFL
11
248
Palliative
Tarlatamab
SCLC
Tarlatamab
11
259
Palliative
CVD for thyroid cancer
Neuroendocrine cancer
CVD for thyroid cancer
11
261
Salvage
IRd
Multiple Myeloma
IRd
11
288
Medicine
ATRA syndrome
Special Medicine
ATRA syndrome
11
319
Palliative
T- deruxtecan (ENHERTU)
Gastric cancer
T- deruxtecan (ENHERTU)
12
39
Palliative
FOLFOX
Esophageal cancer
FOLFOX
12
75
Palliative
Docetaxel + Platinum
Breast cancer (Advanced)
Docetaxel + Platinum
12
138
Palliative
S
Neuroendocrine cancer
S
12
154
Salvage
FC for indolent lymphoma
B-NHL
FC for indolent lymphoma
12
241
Palliative
CMF
Head and Neck cancer
CMF
12
237
Medicine
Extra-vasation
Special Medicine
Extra-vasation
12
198
Salvage
Daratumumab
Multiple Myeloma
Daratumumab
12
285
Palliative
Etoposide
Esophageal cancer
Etoposide
13
81
Primary
VR-CAP for MCL
B-NHL
VR-CAP for MCL
13
92
Palliative
Paclitaxel + Platinum
Breast cancer (Advanced)
Paclitaxel + Platinum
13
139
Palliative
Weekly MTX
Head and Neck cancer
Weekly MTX
13
260
Salvage
Sd (Selinexor + Dexamethasone)
Multiple Myeloma
Sd (Selinexor + Dexamethasone)
13
290
Medicine
Febrile neutropenia
Special Medicine
Febrile neutropenia
13
299
Palliative
Irinotecan
Esophageal cancer
Irinotecan
14
77
Salvage
Ibrutinib / Zanubrutinib for MCL
B-NHL
Ibrutinib / Zanubrutinib for MCL
14
89
Salvage
Teclistamab (Tecvayli)
Multiple Myeloma
Teclistamab (Tecvayli)
14
175
Palliative
Weekly Paclitaxel
Head and Neck cancer
Weekly Paclitaxel
14
120
Palliative
Abraxane
Breast cancer (Advanced)
Abraxane
14
135
Medicine
Shock management
Special Medicine
Shock management
14
326
Primary
R-MV for PCNSL
B-NHL
R-MV for PCNSL
15
3
Palliative
Pembrolizumab + CTx
Esophageal cancer
Pembrolizumab + CTx
15
79
Palliative
Nivolumab
Head and Neck cancer
Nivolumab
15
113
Palliative
Gemcitabine - Contained
Breast cancer (Advanced)
Gemcitabine - Contained
15
137
Medicine
ICU care
Special Medicine
ICU care
15
328
Salvage
Elranatamab (Elrexfio)
Multiple Myeloma
Elranatamab (Elrexfio)
15
331
Palliative
Nivolumab + XELOX
Esophageal cancer
Nivolumab + XELOX
16
76
Palliative
Capecitabine - Contained
Breast cancer (Advanced)
Capecitabine - Contained
16
136
Salvage
Tafasitamab + Lenalidomide
B-NHL
Tafasitamab + Lenalidomide
16
191
Palliative
Pembrolizumab
Head and Neck cancer
Pembrolizumab
16
268
Primary
VCD for AL Amyloidosis
Multiple Myeloma
VCD for AL Amyloidosis
16
292
Medicine
A.fib / Anti-coagulation
Special Medicine
A.fib / Anti-coagulation
16
327
Palliative
Nivolumab + ipilimumab
Esophageal cancer
Nivolumab + ipilimumab
17
80
Palliative
Eribulin
Breast cancer (Advanced)
Eribulin
17
132
Supportive
Cyto-reduction CTx
B-NHL
Cyto-reduction CTx
17
195
Medicine
Influenza infection
Special Medicine
Influenza infection
17
246
Palliative
Pembrolizumab+FP or FC
Head and Neck cancer
Pembrolizumab+FP or FC
17
269
Supportive
Bisphosphnate
Multiple Myeloma
Bisphosphnate
17
295
Supportive
Cardioxan
B-NHL
Cardioxan
18
1
Palliative
CAP for ACC
Head and Neck cancer
CAP for ACC
18
115
Palliative
Lapatinib + Capecitabine
Breast cancer (Advanced)
Lapatinib + Capecitabine
18
134
Medicine
COVID-19
Special Medicine
COVID-19
18
315
Supportive
Denozumab
Breast cancer (Advanced)
Denozumab
19
122
Palliative
Lenvatinib for DTC
Head and Neck cancer
Lenvatinib for DTC
19
267
Medicine
CMV infection / PJP infection
Special Medicine
CMV infection / PJP infection
19
316
Medicine
Fungal infection
Special Medicine
Fungal infection
20
317
Medicine
Bacterial infection
Special Medicine
Bacterial infection
22
332
Regimen contents & editor
Oncology
Hematology
Others
Palliative
Adjuvnat
Neoadjuvant
Perioperative
Definitive
Induction
Reinduction
Consolidation
Primary
Salvage
Maintenance
Alternative
Conditioning
Prophylaxis
Supportive
Medicine
Special
Document
급여
부분
사전
비급여
Schedule
No.
Dosage calculation tool
Hight (cm)
Body Weight (kg)
IBW (kg) |
M
F
Adjusted IBW (kg)
BSA (Mosteller, m²)
BSA (DuBios, m²)
mg/m²
mg
mg
mg/kg
mg
eGFR (mL/min)
AUC
mg
Full
90%
80%
75%
70%
50%
※
●
•
▶
√
≥
≤
±
→
←
↑
↓
↔
m²
µ
10³
Tools and Calulators
CTCAE 5.0
Lymphoma
Myeloma